By targeting inflammation, omega-3s may enhance the efficacy of traditional antidepressants and improve outcomes for patients who have not responded well to conventional therapies.
This exploratory clinical trial indicates that higher doses of omega-3 fatty acids improves motivational symptoms and cognition in depressed individuals exhibiting a pro-inflammatory phenotype.